Scilex Holding Co (SCLX) Form 10-Q Quarterly Reports
Scilex Holding Co (SCLX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SCLX
CIK: 1820190
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BPM LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerMichael VanderKlugt
Audit LocationWalnut Creek, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-25 | 8-K | 0001193125-26-407333 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-24 | — | SCHEDULE 13D/A Filing | 0001193125-26-363607 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | 4 | 0001193125-26-363594 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-352464 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-08 | 8-K | 0001193125-26-347186 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-18 | 8-K | 0001193125-26-312591 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-07 | — | SCHEDULE 13D/A Filing | 0001193125-26-297859 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-03 | 4 | 0001193125-26-297858 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-07-03 | 8-K | 0001193125-26-295493 | View SEC Doc Filr Page |
| S-8 | 2026-06-30 | — | S-8 | 0001193125-26-288861 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-24 | 8-K | 0001193125-26-288677 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-26 | — | SCHEDULE 13D/A Filing | 0001193125-26-285542 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-15 | 4 | 0001193125-26-285524 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-24 | 8-K | 0001193125-26-281213 | View SEC Doc Filr Page |
| EFFECT | 2026-06-11 | — | EFFECT Filing | 9999999995-26-001971 | View SEC Doc Filr Page |
| CORRESP | 2026-06-09 | — | CORRESP Filing | 0001193125-26-264538 | View SEC Doc Filr Page |
| UPLOAD | 2026-06-09 | — | UPLOAD Filing | 0000000000-26-005809 | View SEC Doc Filr Page |
| S-3 | 2026-06-02 | — | S-3 | 0001193125-26-253831 | View SEC Doc Filr Page |
| EFFECT | 2026-05-22 | — | EFFECT Filing | 9999999995-26-001743 | View SEC Doc Filr Page |
| 10-Q | 2026-05-20 | 2026-03-31 | 10-Q | 0001193125-26-232857 | View SEC Doc Filr Page |
| CORRESP | 2026-05-20 | — | CORRESP Filing | 0001193125-26-232858 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NT 10-Q | 0001193125-26-226675 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001193125-26-216921 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-05 | — | DEFA14A | 0001193125-26-206367 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-04 | 8-K | 0001193125-26-205839 | View SEC Doc Filr Page |